key: cord-0732623-i9zbfpa5
authors: de Sene, Diogo Ribeiro; Watashi, Diego Moreno; Bilitardo, Isabella de Oliveira; Moreno, Carlos Eduardo Campos; Moreno, Mariella Freire de Freitas
title: COVID-19 presenting as persistent hiccups: a case report
date: 2021-08-06
journal: Revista do Instituto de Medicina Tropical de Sao Paulo
DOI: 10.1590/s1678-9946202163062
sha: 9ee5f137f2a9a0590bd3645f4ee45cb4d14054c3
doc_id: 732623
cord_uid: i9zbfpa5

Hiccups are involuntary, spasmodic contractions of the diaphragm and intercostal muscles and can be classified as acute (< 48 h), persistent (48 h to a month) or intractable (> 1 month). A previously healthy 29-year-old man sought the Emergency Department with flu-like symptoms and a two-day history of persistent hiccups. His physical examination was otherwise unremarkable and vital signs were within normal limits. An unenhanced computed tomography scan of the chest showed small focal ground-glass opacities scattered throughout 25% of the lungs. A COVID-19 test was positive. Chlorpromazine was prescribed for the hiccups with improvement over 10 h. The patient was discharged home on the same day without hiccups and no other complications.

Hiccups are diaphragmatic and intercostal muscle contractions with early glottis closure terminating the inspiration. They are involuntary and spasmodic, and are controlled by a complex reflex arc between peripheral receptors and the brainstem. Any disruption along this pathway may produce hiccups. Hiccups can be classified as acute (< 48 h), persistent (48 h to a month) or intractable (> 1 month). Most acute hiccups are transient, benign and self-limited. However, persistent and intractable hiccups may be considered a sign of underlying pathology and although the most common cause is gastroesophageal reflux disease (GERD), atypical causes as COVID-19 are now identified in rare reports in the literature 1,2 .

A 29-year old man sought the Emergency Department complaining of hiccups in the last 2 days. The patient reported one febrile episode of 37.8 o C which improved after the use of acetaminophen, and a 3-day history of cough, rhinorrhea and mild shortness of breathe. Upon admission, he denied feeling tightness in his chest or a sore throat. The patient had no previous history of chronic diseases or allergies and denied abuse of alcohol, other drugs and was not a smoker. His blood pressure was 132/74 cmHg, the respiratory rate was 20 breaths/min, his heart rate was 73 beats/min and regular, the body temperature was 36.4 o C and the oxygen saturation was 94% in room air. There were bilateral scattered crackles during the auscultation of the lungs and no signs of respiratory insufficiency. The head and the neurological examination were normal. Routine blood test results were as follows: red blood cells 4.74 x 10 6 cells/uL; white blood cells 7.75 x 10 3 cells/uL; neutrophils 81.2%; lymphocytes 13.4%; total number of lymphocytes 1.039 x 10 3 cells/uL; platelets 194 x 10 3 cells/uL; C-reactive protein (CRP) 32 mg/L; potassium4.2 mEq/L; sodium137 mEq/L; BUN 15.4 mg/dL; serum creatinine (Cr) 1.04 mg/dL; D-dimer 142 ng/mL; lactate dehydrogenase (LDH) 179 U/L; ferritin 245 ng/mL; troponin 1.4 pg/mL. His arterial blood gas analysis was as follows: pH 7.41; pCO 2 36 mmHg; pO 2 83 mmHg; Oxygen saturation 96%; HCO 3 22.8 mEq/L; Base excess -2.1 mEq/L.

The chest computed tomography (CT) was performed and small subpleural ground-glass opacities, as well as small sparse areas of atelectasis were observed scattered across the two lungs and affecting less than 25% of lung parenchyma, suggesting the presence of a viral pneumonia ( Figure 1) . A real-time reverse transcription-polymerase chain reaction (RT-PCR) analysis of the patient's throat swab sample confirmed the SARS-Cov-2 infection. The Valsalva maneuver used in an attempt to stop the hiccups was unsuccessful. As the patient did not meet the Centers for Disease Control and Prevention (CDC) established criteria for COVID-19 severe illness, he was discharged home with symptomatic medication 3 . The patient was followed-up by phone for 10 days and treated with chlorpromazine for the resistant hiccups, which disappeared 10 h after starting treatment. The chlorpromazine treatment was continued for three days, for a total of five days, and there was no relapse after treatment discontinuation.

Since the first COVID-19 report, clinical manifestations were described in most cases as fever, nonproductive cough, dyspnea, myalgia, fatigue, normal or decreased leukocyte count, in addition to radiographic evidence of pneumonia in the chest CT scan.

The severe presentation of COVID-19 included organ dysfunction, clinically presenting as shock, acute respiratory distress syndrome (ARDS), acute cardiac injury, acute kidney injury and death 4 . However, with the growing COVID-19 data around the world, different presentations have been reported, highlighting the clinical heterogeneity of this disease. This case reports a patient with an atypical presentation: persistent hiccups 5 .

The correlation between COVID-19 and hiccups still remains unclear, but other infectious conditions such as influenza, herpes zoster, neurosyphilis and tuberculosis have been related to hiccups 6, 7 .

The severity and treatment of hiccups depend on their temporal classification. Acute hiccups are usually benign and self-limited, not requiring intervention or etiological investigation in the majority of cases. However, patients whose hiccups interfere with their quality of life may attempt physical maneuvers to relieve their symptoms. These maneuvers are harmless to the patient and they work by increasing the vagal stimulus, interrupting the normal respiratory rhythm an the nasopharynx stimulus. There are several methods: breath holding, Valsalva's maneuver, eyeball compression, drinking cold water, pulling out the tongue, among others 6, 8 .

Persistent hiccups usually interfere with the patient's daily activities and they often hide a pathological etiology, therefore the underlying cause should be investigated. Some common causes are gastroesophageal reflux (GERD), malignancies, myocardial infarction, cerebrovascular diseases, medications, toxic metabolites, infectious agents, among others. Physical maneuvers may be initially attempted in order to relieve the symptoms, but in contrast to acute hiccups, persistent and intractable hiccups are less likely to be terminated by physical therapy.

The treatment should always be focused on the underlying cause, but an empiric treatment can be used while the etiology is under investigation. The first empiric option should be a proton pump inhibitor, as the most common cause of persistent hiccups is GERD. In the absence of symptoms improvement or the diagnosis of a serious etiology, a wide variety of medications can be used. The most common options are baclofen, gabapentin, metoclopramide and chlorpromazine 6 . In our case, chlorpromazine was used as the first option due to the drug availability. Similar case reports of COVID-19 associated with hiccups are presented in Table 1 . Briefly, including the case reported here, there are 10 cases of COVID-19 (confirmed by RT-PCR) associated with hiccups in the literature, all of them in male patients aged 29-68 years, with abnormal chest CT scan or chest X-rays of the lungs, all patients but one received medications to stop the hiccups, and according to the follow-up description, eight patients evolved with improvement of symptoms, including ours, one case was lost to follow-up, and in one case data were not available in the medical record.

During the COVID-19 pandemic, health care workers must maintain a high clinical suspicion of COVID-19 examining patients with atypical presentations of this disease, such as persistent hiccups. 

Managing hiccups

Chronic hiccups. Curr Treat Options Gastroenterol

Interim clinical guidance for management of patients with confirmed Coronavirus disease (COVID-19)

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Persistent hiccups as an atypical presenting complaint of COVID-19

Management of hiccups in palliative care patients

Treasure Island: StatPearls

Systemic review: the pathogenesis and pharmacological treatment of hiccups

Persistent hiccups in a patient with mild congenital factor V deficiency and COVID-19; clinical and laboratory finding of a rare bleeding disorder

Two cases of persistent hiccups complicating COVID-19

Persistent hiccup: a rare presentation of COVID-19

Hiccups and psychosis: two atypical presentations of COVID-19

Persistent hiccups as main COVID-19 symptom

Hiccups and hyponatremia: unusual co-presentation in COVID-19

A rare case report of persistent hiccups as an atypical presentation of COVID-19

Levosulpiride relieved persistent hiccups in a patient With COVID-19 and vascular cognitive impairment